Dona Jean Leonard, MS, OTR, CEASII Occupational Therapist - Environmental Modification Medicare: Not Enrolled in Medicare Practice Location: 4921 Saddlewood Cir, Johnstown, CO 80534 Phone: 970-420-6049 Fax: 970-200-8359 |
Carolyn Rose Coates, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4435 Ronald Reagan Blvd, Johnstown, CO 80534 Phone: 650-380-4504 |
Ambra Taylor, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4355 Yarrow Ln, Johnstown, CO 80534 Phone: 970-663-4247 |
Bauer Occupational Therapy, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 442 La Costa Ln, Johnstown, CO 80534 Phone: 970-590-6827 |
Mandie Schake, MOTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4401 Union St, Johnstown, CO 80534 Phone: 970-619-3400 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.
In a cutting-edge treatment for Alzheimer's disease, EPFL scientists have developed an implantable capsule that can turn the patient's immune system against the disease.
Cancer-related effects and the treatment itself can have a significant psychosocial impact on cancer survivors. A recent study (STEP study) that assessed over 1800 cancer survivors across ten countries in Asia Pacific was presented at the ESMO Asia Congress today.
Scientists at Queen's University Belfast are hoping to develop a novel approach that could save the sight of millions of diabetes sufferers using adult stem cells.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
› Verified 9 days ago